3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Papillomavirus Infections
4
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Sarcoma
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Osteoporosis
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Infertility, Female
1
Elective Surgery for Any Digestive Cancer
1
Crohn Disease
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Ductal Infiltrating Metastatic
1
Barrett Esophagus
1
Airway Obstruction
1
Interventions
Metformin
21
Letrozole
11
Clomiphene
7
dapagliflozin
4
Contraceptives, Oral
4
Chorionic Gonadotropin
4
cetrorelix
3
Liraglutide
3
Inositol
3
follitropin beta
2
follitropin alfa
2
drospirenone and ethinyl estradiol combination
2
Musculoskeletal Manipulations
2
Glycoprotein Hormones, alpha Subunit
2
DLBS3233
2
Cholecalciferol
2
semaglutide
1
saxagliptin
1
lime
1
follicle stimulating hormone, human, with HCG C-terminal peptide
1
drospirenone
1
cinnulin PF
1
Urofollitropin
1
Triptorelin Pamoate
1
Treatment Expectations
1
Thioctic Acid
1
Tamoxifen
1
Tablets
1
Sugars
1
Sperm Injections, Intracytoplasmic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Polycystic Ovary Syndrome
×
Blood Specimen Collection
×
Clear all
NCT03197077
2023-04-07
Elonva_IVM
Universitair Ziekenhuis Brussel
Phase 3
Completed
145 enrolled